Literature DB >> 11813878

Expression, function and clinical relevance of MIA (melanoma inhibitory activity).

A K Bosserhoff1, R Buettner.   

Abstract

Despite its ambiguous name the protein melanoma-inhibitory-activity (MIA) was identified as a key molecule involved in progression and metastasis of malignant melanomas. Therefore, in this review we intend to update the current knowledge on expression patterns, transcriptional regulation, function and clinical relevance of MIA. Furthermore, we will cover the recently discovered MIA homologous proteins OTOR/MIAL, MIA 2 and TANGO. In order to identify autocrine growth-regulatory factors secreted by melanoma cells, MIA was purified and cloned. Subsequent analyses of non-neoplastic tissues revealed specific MIA expression patterns in cartilage. In neoplastic tissues MIA expression was detected in malignant melanomas, in chondrosarcomas and less frequently in a variety of different adenocarcinomas including breast and colon cancers. For melanoma cells and chondrocytes it was shown that regulation of expression pattern was controlled on the level of mRNA transcription by defined transcription factors. Evidence obtained from in vitro and in vivo experiments indicated that MIA plays an important functional role in melanoma metastasis and invasion. A number of studies from different laboratories evaluated MIA as a highly specific and sensitive marker, clinically useful for follow-up and therapy-monitoring of patients with malignant melanomas. In addition, preliminary data suggests a further potential application as a surrogate marker for measuring cartilage damage in rheumatoid arthritis. Recently, it has become evident that MIA belongs to a gene family of four homologous proteins, MIA, OTOR (FDP, MIAL), MIA 2 and TANGO. Determination of the three-dimensional structure in solution identified MIA as the first member of this novel family of secreted, extracellular proteins adopting an SH3 domain-like fold. The data suggest specific protein-protein interactions with components of the extracellular matrix and possibly epitopes on cellular surfaces and will certainly attract further interest and investigations.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11813878     DOI: 10.14670/HH-17.289

Source DB:  PubMed          Journal:  Histol Histopathol        ISSN: 0213-3911            Impact factor:   2.303


  29 in total

1.  Pitfalls in immunohistochemistry--a recent example.

Authors:  Alexander Riechers; Anja Katrin Bosserhoff
Journal:  Int J Clin Exp Pathol       Date:  2012-02-12

Review 2.  Protein export at the ER: loading big collagens into COPII carriers.

Authors:  Vivek Malhotra; Patrik Erlmann
Journal:  EMBO J       Date:  2011-08-31       Impact factor: 11.598

Review 3.  New insights in melanoma biomarkers: long-noncoding RNAs.

Authors:  Ricardo Moreno-Traspas; Igor Vujic; Martina Sanlorenzo; Susana Ortiz-Urda
Journal:  Melanoma Manag       Date:  2016-08-16

4.  Comparison of modern marker proteins in serum and synovial fluid in patients with advanced osteoarthrosis and rheumatoid arthritis.

Authors:  S Andereya; N Streich; B Schmidt-Rohlfing; T Mumme; R Müller-Rath; U Schneider
Journal:  Rheumatol Int       Date:  2005-07-06       Impact factor: 2.631

5.  [Serum markers for melanoma].

Authors:  S Ugurel
Journal:  Hautarzt       Date:  2005-02       Impact factor: 0.751

Review 6.  Circulating serologic and molecular biomarkers in malignant melanoma.

Authors:  Shanique R Palmer; Lori A Erickson; Ilia Ichetovkin; Daniel J Knauer; Svetomir N Markovic
Journal:  Mayo Clin Proc       Date:  2011-10       Impact factor: 7.616

7.  Genetic variants identified in a European genome-wide association study that were found to predict incident coronary heart disease in the atherosclerosis risk in communities study.

Authors:  Jan Bressler; Aaron R Folsom; David J Couper; Kelly A Volcik; Eric Boerwinkle
Journal:  Am J Epidemiol       Date:  2009-12-02       Impact factor: 4.897

8.  Misexpression of MIA disrupts lung morphogenesis and causes neonatal death.

Authors:  Sui Lin; Machiko Ikegami; Yan Xu; Anja-Katrin Bosserhoff; Alvin M Malkinson; John M Shannon
Journal:  Dev Biol       Date:  2008-02-15       Impact factor: 3.582

9.  Genome-wide association study of coronary artery disease.

Authors:  Naomi Ogawa; Yasushi Imai; Hiroyuki Morita; Ryozo Nagai
Journal:  Int J Hypertens       Date:  2010-09-21       Impact factor: 2.420

10.  Melanoma biomarkers: Vox clamantis in deserto (Review).

Authors:  Mays Al-Shaer; Divya Gollapudi; Chris Papageorgio
Journal:  Oncol Lett       Date:  2010-05-01       Impact factor: 2.967

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.